 | • レポートコード：GIR201109866 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、トランスサイレチンの世界市場を調査対象にし、トランスサイレチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（）、用途別分析（家族性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Alnylam Pharmaceuticals Inc、Neurimmune Holding AG、Arcturus Therapeutics Inc、Regeneron Pharmaceuticals Inc、Ionis Pharmaceuticals Inc、Prothena Corp Plc、Pfizer Inc ・メーカー別販売量、売上、市場シェア ・トランスサイレチンの地域別市場分析 ・トランスサイレチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・トランスサイレチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・トランスサイレチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・トランスサイレチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・トランスサイレチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・トランスサイレチンの種類別市場規模2015-2020： ・トランスサイレチンの用途別市場規模2015-2020：家族性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他 ・トランスサイレチンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Transthyretin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Transthyretin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Transthyretin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Transthyretin market has been segmented into
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
By Application, Transthyretin has been segmented into:
Familial Amyloid Neuropathies
Alzheimer’s Disease
Cardomyopathy
Neuropathy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Transthyretin market presented in the report. This section sheds light on the sales growth of different regional and country-level Transthyretin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Transthyretin market.
The report offers in-depth assessment of the growth and other aspects of the Transthyretin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Transthyretin Market Share Analysis
Transthyretin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Transthyretin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Transthyretin sales, revenue and market share for each player covered in this report.
The major players covered in Transthyretin are:
Alnylam Pharmaceuticals Inc
Neurimmune Holding AG
Arcturus Therapeutics Inc
Regeneron Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Prothena Corp Plc
Pfizer Inc
Among other players domestic and global, Transthyretin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transthyretin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transthyretin, with price, sales, revenue and global market share of Transthyretin in 2018 and 2019.
Chapter 3, the Transthyretin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transthyretin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Transthyretin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Transthyretin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Transthyretin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transthyretin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AG-10
1.2.3 ALN-TTRsc02
1.2.4 CRX-1008
1.2.5 EDE-1307
1.2.6 Inotersen Sodium
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Transthyretin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Familial Amyloid Neuropathies
1.3.3 Alzheimer’s Disease
1.3.4 Cardomyopathy
1.3.5 Neuropathy
1.3.6 Others
1.4 Overview of Global Transthyretin Market
1.4.1 Global Transthyretin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alnylam Pharmaceuticals Inc
2.1.1 Alnylam Pharmaceuticals Inc Details
2.1.2 Alnylam Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alnylam Pharmaceuticals Inc SWOT Analysis
2.1.4 Alnylam Pharmaceuticals Inc Product and Services
2.1.5 Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Neurimmune Holding AG
2.2.1 Neurimmune Holding AG Details
2.2.2 Neurimmune Holding AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Neurimmune Holding AG SWOT Analysis
2.2.4 Neurimmune Holding AG Product and Services
2.2.5 Neurimmune Holding AG Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Arcturus Therapeutics Inc
2.3.1 Arcturus Therapeutics Inc Details
2.3.2 Arcturus Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Arcturus Therapeutics Inc SWOT Analysis
2.3.4 Arcturus Therapeutics Inc Product and Services
2.3.5 Arcturus Therapeutics Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Regeneron Pharmaceuticals Inc
2.4.1 Regeneron Pharmaceuticals Inc Details
2.4.2 Regeneron Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Regeneron Pharmaceuticals Inc SWOT Analysis
2.4.4 Regeneron Pharmaceuticals Inc Product and Services
2.4.5 Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ionis Pharmaceuticals Inc
2.5.1 Ionis Pharmaceuticals Inc Details
2.5.2 Ionis Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ionis Pharmaceuticals Inc SWOT Analysis
2.5.4 Ionis Pharmaceuticals Inc Product and Services
2.5.5 Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Prothena Corp Plc
2.6.1 Prothena Corp Plc Details
2.6.2 Prothena Corp Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Prothena Corp Plc SWOT Analysis
2.6.4 Prothena Corp Plc Product and Services
2.6.5 Prothena Corp Plc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer Inc
2.7.1 Pfizer Inc Details
2.7.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer Inc SWOT Analysis
2.7.4 Pfizer Inc Product and Services
2.7.5 Pfizer Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Transthyretin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Transthyretin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Transthyretin Manufacturer Market Share in 2019
3.3.2 Top 6 Transthyretin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Transthyretin Sales, Revenue and Market Share by Regions
4.1.1 Global Transthyretin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Transthyretin Revenue and Market Share by Regions (2015-2020)
4.2 North America Transthyretin Sales and Growth Rate (2015-2020)
4.3 Europe Transthyretin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Transthyretin Sales and Growth Rate (2015-2020)
4.5 South America Transthyretin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Transthyretin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Transthyretin Sales, Revenue and Market Share by Country
5.1.1 North America Transthyretin Sales and Market Share by Country (2015-2020)
5.1.2 North America Transthyretin Revenue and Market Share by Country (2015-2020)
5.2 United States Transthyretin Sales and Growth Rate (2015-2020)
5.3 Canada Transthyretin Sales and Growth Rate (2015-2020)
5.4 Mexico Transthyretin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Transthyretin Sales, Revenue and Market Share by Country
6.1.1 Europe Transthyretin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Transthyretin Revenue and Market Share by Country (2015-2020)
6.2 Germany Transthyretin Sales and Growth Rate (2015-2020)
6.3 UK Transthyretin Sales and Growth Rate (2015-2020)
6.4 France Transthyretin Sales and Growth Rate (2015-2020)
6.5 Russia Transthyretin Sales and Growth Rate (2015-2020)
6.6 Italy Transthyretin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Transthyretin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Transthyretin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Transthyretin Revenue and Market Share by Regions (2015-2020)
7.2 China Transthyretin Sales and Growth Rate (2015-2020)
7.3 Japan Transthyretin Sales and Growth Rate (2015-2020)
7.4 Korea Transthyretin Sales and Growth Rate (2015-2020)
7.5 India Transthyretin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Transthyretin Sales and Growth Rate (2015-2020)
7.7 Australia Transthyretin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Transthyretin Sales, Revenue and Market Share by Country
8.1.1 South America Transthyretin Sales and Market Share by Country (2015-2020)
8.1.2 South America Transthyretin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Transthyretin Sales and Growth Rate (2015-2020)
8.3 Argentina Transthyretin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Transthyretin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Transthyretin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Transthyretin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Transthyretin Sales and Growth Rate (2015-2020)
9.3 Turkey Transthyretin Sales and Growth Rate (2015-2020)
9.4 Egypt Transthyretin Sales and Growth Rate (2015-2020)
9.5 South Africa Transthyretin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Transthyretin Sales and Market Share by Type (2015-2020)
10.2 Global Transthyretin Revenue and Market Share by Type (2015-2020)
10.3 Global Transthyretin Price by Type (2015-2020)
11 Global Transthyretin Market Segment by Application
11.1 Global Transthyretin Sales Market Share by Application (2015-2020)
11.2 Global Transthyretin Revenue Market Share by Application (2015-2020)
11.3 Global Transthyretin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Transthyretin Sales, Revenue and Growth Rate (2021-2025)
12.2 Transthyretin Market Forecast by Regions (2021-2025)
12.2.1 North America Transthyretin Market Forecast (2021-2025)
12.2.2 Europe Transthyretin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Transthyretin Market Forecast (2021-2025)
12.2.4 South America Transthyretin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Transthyretin Market Forecast (2021-2025)
12.3 Transthyretin Market Forecast by Type (2021-2025)
12.3.1 Global Transthyretin Sales Forecast by Type (2021-2025)
12.3.2 Global Transthyretin Market Share Forecast by Type (2021-2025)
12.4 Transthyretin Market Forecast by Application (2021-2025)
12.4.1 Global Transthyretin Sales Forecast by Application (2021-2025)
12.4.2 Global Transthyretin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Transthyretin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Transthyretin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Transthyretin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Alnylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 8. Alnylam Pharmaceuticals Inc Transthyretin Major Business
Table 9. Alnylam Pharmaceuticals Inc Transthyretin Total Revenue (USD Million) (2018-2019)
Table 10. Alnylam Pharmaceuticals Inc SWOT Analysis
Table 11. Alnylam Pharmaceuticals Inc Transthyretin Product and Services
Table 12. Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Neurimmune Holding AG Basic Information, Manufacturing Base and Competitors
Table 14. Neurimmune Holding AG Transthyretin Major Business
Table 15. Neurimmune Holding AG Transthyretin Total Revenue (USD Million) (2018-2019)
Table 16. Neurimmune Holding AG SWOT Analysis
Table 17. Neurimmune Holding AG Transthyretin Product and Services
Table 18. Neurimmune Holding AG Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Arcturus Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 20. Arcturus Therapeutics Inc Transthyretin Major Business
Table 21. Arcturus Therapeutics Inc Transthyretin Total Revenue (USD Million) (2018-2019)
Table 22. Arcturus Therapeutics Inc SWOT Analysis
Table 23. Arcturus Therapeutics Inc Transthyretin Product and Services
Table 24. Arcturus Therapeutics Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 26. Regeneron Pharmaceuticals Inc Transthyretin Major Business
Table 27. Regeneron Pharmaceuticals Inc Transthyretin Total Revenue (USD Million) (2018-2019)
Table 28. Regeneron Pharmaceuticals Inc SWOT Analysis
Table 29. Regeneron Pharmaceuticals Inc Transthyretin Product and Services
Table 30. Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Ionis Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 32. Ionis Pharmaceuticals Inc Transthyretin Major Business
Table 33. Ionis Pharmaceuticals Inc Transthyretin Total Revenue (USD Million) (2018-2019)
Table 34. Ionis Pharmaceuticals Inc SWOT Analysis
Table 35. Ionis Pharmaceuticals Inc Transthyretin Product and Services
Table 36. Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Prothena Corp Plc Basic Information, Manufacturing Base and Competitors
Table 38. Prothena Corp Plc Transthyretin Major Business
Table 39. Prothena Corp Plc Transthyretin Total Revenue (USD Million) (2018-2019)
Table 40. Prothena Corp Plc SWOT Analysis
Table 41. Prothena Corp Plc Transthyretin Product and Services
Table 42. Prothena Corp Plc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Inc Transthyretin Major Business
Table 45. Pfizer Inc Transthyretin Total Revenue (USD Million) (2018-2019)
Table 46. Pfizer Inc SWOT Analysis
Table 47. Pfizer Inc Transthyretin Product and Services
Table 48. Pfizer Inc Transthyretin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Transthyretin Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Transthyretin Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Transthyretin Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Transthyretin Sales Market Share by Regions (2015-2020)
Table 53. Global Transthyretin Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Transthyretin Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Transthyretin Sales Market Share by Countries (2015-2020)
Table 56. North America Transthyretin Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Transthyretin Revenue Market Share by Countries (2015-2020)
Table 58. Europe Transthyretin Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Transthyretin Sales Market Share by Countries (2015-2020)
Table 60. Europe Transthyretin Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Transthyretin Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Transthyretin Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Transthyretin Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Transthyretin Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Transthyretin Sales Market Share by Countries (2015-2020)
Table 66. South America Transthyretin Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Transthyretin Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Transthyretin Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Transthyretin Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Transthyretin Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Transthyretin Revenue Market Share by Countries (2015-2020)
Table 72. Global Transthyretin Sales by Type (2015-2020) (K Pcs)
Table 73. Global Transthyretin Sales Share by Type (2015-2020)
Table 74. Global Transthyretin Revenue by Type (2015-2020) (USD Million)
Table 75. Global Transthyretin Revenue Share by Type (2015-2020)
Table 76. Global Transthyretin Sales by Application (2015-2020) (K Pcs)
Table 77. Global Transthyretin Sales Share by Application (2015-2020)
Table 78. Global Transthyretin Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Transthyretin Market Share Forecast by Regions (2021-2025)
Table 80. Global Transthyretin Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Transthyretin Market Share Forecast by Type (2021-2025)
Table 82. Global Transthyretin Sales Forecast by Application (2021-2025)
Table 83. Global Transthyretin Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Transthyretin Picture
Figure 2. Global Sales Market Share of Transthyretin by Type in 2019
Figure 3. AG-10 Picture
Figure 4. ALN-TTRsc02 Picture
Figure 5. CRX-1008 Picture
Figure 6. EDE-1307 Picture
Figure 7. Inotersen Sodium Picture
Figure 8. Others Picture
Figure 9. Transthyretin Sales Market Share by Application in 2018
Figure 10. Familial Amyloid Neuropathies Picture
Figure 11. Alzheimer's Disease Picture
Figure 12. Cardomyopathy Picture
Figure 13. Neuropathy Picture
Figure 14. Others Picture
Figure 15. Global Transthyretin Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Transthyretin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Transthyretin Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Transthyretin Sales Market Share by Manufacturer in 2019
Figure 36. Global Transthyretin Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Transthyretin Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Transthyretin Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 41. Global Transthyretin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Transthyretin Revenue Market Share by Regions (2015-2020)
Figure 43. Global Transthyretin Revenue Market Share by Regions in 2018
Figure 44. North America Transthyretin Sales and Growth Rate (2015-2020)
Figure 45. Europe Transthyretin Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Transthyretin Sales and Growth Rate (2015-2020)
Figure 47. South America Transthyretin Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Transthyretin Sales and Growth Rate (2015-2020)
Figure 49. North America Transthyretin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Transthyretin Sales Market Share by Countries (2015-2020)
Figure 51. North America Transthyretin Sales Market Share by Countries in 2018
Figure 52. North America Transthyretin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Transthyretin Revenue Market Share by Countries in 2018
Figure 54. United States Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Canada Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Mexico Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Europe Transthyretin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Transthyretin Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Transthyretin Revenue Market Share by Countries in 2019
Figure 60. Germany Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. UK Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. France Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Italy Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Asia-Pacific Transthyretin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Transthyretin Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Transthyretin Revenue Market Share by Regions 2019
Figure 68. China Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Korea Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. India Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Southeast Asia Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. South America Transthyretin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Transthyretin Sales Market Share by Countries in 2019
Figure 75. South America Transthyretin Revenue Market Share by Countries in 2019
Figure 76. Brazil Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Argentina Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Middle East and Africa Transthyretin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Transthyretin Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Transthyretin Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Transthyretin Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Egypt Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Turkey Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. South Africa Transthyretin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Global Transthyretin Sales and Growth Rate (2021-2025) (K Pcs)
Figure 87. Global Transthyretin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Transthyretin Market Forecast (2021-2025) (K Pcs)
Figure 89. Europe Sales Transthyretin Market Forecast (2021-2025) (K Pcs)
Figure 90. Asia-Pacific Sales Transthyretin Market Forecast (2021-2025) (K Pcs)
Figure 91. South America Sales Transthyretin Market Forecast (2021-2025) (K Pcs)
Figure 92. Middle East & Africa Sales Transthyretin Market Forecast (2021-2025) (K Pcs)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
アルツハイマー病治療薬の世界市場 2020年 Market Overview The Alzheimer's Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- アルツハイマー病治療の世界市場 2020年 Market Overview The global Alzheimer's Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer's Di…
- ヘテロ接合性家族性高コレステロール血症薬の世界市場 2020年 Market Overview The global Heterozygous Familial Hypercholesterolemia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- 膵島アミロイドポリペプチドの世界市場 2020年 Market Overview The global Islet Amyloid Polypeptide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Islet Amyloid Polyp…
- ホモ接合型家族性高コレステロール血症治療の世界市場 2020年 Market Overview The global Homozygous Familial Hypercholesterolemia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019…